Matches in Nanopublications for { ?s ?p "[The only difference is that patients with PKD2 mutations run a milder course compared to PKD1 carriers, with an average 10-20 years later age of onset and lower probability to reach end-stage-renal failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP283631.RAuguc31Gvof3LlzlqlqapYhdcUcj0nuJDxB-0IJnyulI130_assertion description "[The only difference is that patients with PKD2 mutations run a milder course compared to PKD1 carriers, with an average 10-20 years later age of onset and lower probability to reach end-stage-renal failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283631.RAuguc31Gvof3LlzlqlqapYhdcUcj0nuJDxB-0IJnyulI130_provenance.
- assertion description "[The only difference is that patients with PKD2 mutations run a milder course compared to PKD1 carriers, with an average 10-20 years later age of onset and lower probability to reach end-stage-renal failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The only difference is that patients with PKD2 mutations run a milder course compared to PKD1 carriers, with an average 10-20 years later age of onset and lower probability to reach end-stage-renal failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.